News tagged with ms
'Buckyballs' to treat multiple sclerosis
If you're of a certain age, you'll remember Buckminster Fuller's distinctive "geodesic domes" - soccer-ball-shaped structures that the late futurist envisioned as ideal human domiciles. Tel Aviv University ...
Nanotechnology / Bio & Medicine
Mar 19, 2009 |
5 / 5 (3) |
1
MS research: Myelin influences how brain cells send signals
The development of a new cell-culture system that mimics how specific nerve cell fibers in the brain become coated with protective myelin opens up new avenues of research about multiple sclerosis. Initial findings suggest ...
Jul 21, 2011 |
5 / 5 (2) |
0
|
E-reader Roundup At The 2010 CES
(PhysOrg.com) -- At the 2010 Las Vegas CES, many manufactures introduced their e-reader products in the hope to spark consumer interest in the e-book market. 2010 is going to prove to be an innovative year ...
Electronics / Consumer & Gadgets
Jan 12, 2010 |
4.7 / 5 (3) |
0
|
Advance toward a breath test to diagnose multiple sclerosis
Scientists are reporting the development and successful tests in humans of a sensor array that can diagnose multiple sclerosis (MS) from exhaled breath, an advance that they describe as a landmark in the long ...
Chemistry / Analytical Chemistry
Oct 26, 2011 |
5 / 5 (2) |
0
Drug improves mobility for some MS patients
The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis (MS). That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published ...
Medicine & Health / Medications
Feb 27, 2009 |
4.3 / 5 (3) |
0
Stem cells from fat tissue offer hope for MS treatment
A preliminary study on the use of stem cells obtained from a patient's own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results. The three case studies, described in BioMed Central's open ...
Medicine & Health / Medical research
Apr 24, 2009 |
5 / 5 (3) |
0
Marijuana use may hurt intellectual skills in MS patients
Any possible pain relief that marijuana has for people with multiple sclerosis (MS) may be outweighed by the drug's apparent negative effect on thinking skills, according to research published in the March 29, 2011, print ...
Medicine & Health / Neuroscience
Mar 28, 2011 |
1.8 / 5 (4) |
8
New research may lead to therapy that delays onset, reduces severity of MS symptoms
People suffering from multiple sclerosis may benefit if patent-pending research conducted at Purdue University shows that a decades-old drug approved by the FDA to treat hypertension also can delay the onset ...
Medicine & Health / Neuroscience
Mar 15, 2011 |
not rated yet |
0
Canada okays 'liberation therapy' trials
Canada will fund clinical trials for a controversial multiple sclerosis treatment that targets blocked neck veins, Health Minister Leona Aglukkaq announced Wednesday.
Medicine & Health / Medical research
Jun 29, 2011 |
5 / 5 (1) |
0
Study finds twenty percent of children with MS don't respond to first-line treatment
Researchers from the National Network of Pediatric MS Centers of Excellence, in the first retrospective study of the response of children with multiple sclerosis to standard, or first-line, therapies, found that one-fifth ...
Medicine & Health / Neuroscience
Jan 26, 2011 |
3 / 5 (1) |
0
New studies question vascular multiple sclerosis hypothesis and treatment
Two important new studies challenge the controversial hypothesis that venous congestion -- chronic cerebrospinal venous insufficiency (CCSVI) -- contributes to the development of multiple sclerosis (MS). This theory has resulted ...
Medicine & Health / Neuroscience
Aug 02, 2010 |
5 / 5 (1) |
0
Aussie and Kiwi researchers make double MS genetic discovery
Australian and New Zealand researchers have accelerated research into Multiple Sclerosis by discovering two new locations of genes which will help to unravel the causes of MS and other autoimmune disease.
Medicine & Health / Medical research
Jun 14, 2009 |
5 / 5 (1) |
0
Epstein-Barr virus may be associated with progression of MS
Epstein-Barr virus (EBV), the pathogen that causes mononucleosis, appears to play a role in the neurodegeneration that occurs in persons with multiple sclerosis, researchers at the University at Buffalo and the University ...
Medicine & Health / Neuroscience
Mar 02, 2009 |
5 / 5 (1) |
0
Genetic study shows direct link between vitamin D and MS susceptibility 'gene'
Researchers have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS). The research, published on 6 February in the open-access journal ...
Feb 05, 2009 |
5 / 5 (1) |
0
New pill to treat multiple sclerosis
A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.
Medicine & Health / Medications
Apr 30, 2009 |
3.3 / 5 (4) |
0
MSNBC
MSNBC is a 24-hour cable news channel based in the United States and available in both the US and Canada. Its name is a combination of "MSN" and "NBC".
Msnbc.com, a separate company, is the news website for the NBC News family, featuring interactivity and multimedia plus original stories and video which augment the content from NBC News and partners.
Two partnerships with the names MSNBC and msnbc.com were founded in 1996 by Microsoft and General Electric's NBC unit, which is now NBC Universal. Although Microsoft and NBC shared operations of MSNBC cable at its founding, it was announced on December 23, 2005, that NBC Universal would purchase a majority stake in the television network, which left Microsoft with 18%. The two companies remain 50-50 partners in msnbc.com. MSNBC shares the NBC logo of a rainbow peacock with its sister channels NBC, CNBC and ShopNBC.
Critics and observers of the network say that MSNBC has become increasingly politically liberal compared with other networks, particularly in its prime-time lineup.
For more information about MSNBC, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
